We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
Peritoneal Carcinomatosis from Ovarian Cancer
Price data last checked 101 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Description
Ovarian cancer is the most common cause of death among all gynecological neoplasms. Ovarian epithelial cancer represents approximately 90% of all ovarian malignant tumours. The most usual pattern of spread and probably the earliest kind of metastasis of ovarian cancer is intraperitoneal spread, caused by apoptosis of viable cancer cells, even in cases where the ovarian surface has no visible rupture. Approximately 70% to 75% of all ovarian cancers are being diagnosed with peritoneal carcinomatosis and ascites in advanced stages III and IV. Peritoneal carcinomatosis from ovarian cancer may occur either concomitantly with the primary tumour or as a recurrence pattern of spread. Standard treatment consists of surgical debulking and postoperative systemic chemotherapy. Response rates to first-line chemotherapy with platinum/taxane combinations are high, about 70-80%, but the vast majority of patients will relapse. Peritoneal seeding is a major cause of surgical treatment failure among those patients, even after optimal debulking. However, progressing ovarian cancer tends to remain within the peritoneal cavity or, better-expressed, ovarian cancer is a cancer of the peritoneum. The administration of cytotoxic agents directly into the peritoneal cavity as treatment for malignancy was initially evaluated more than 40 years ago. Over the past two decades regional therapy of ovarian cancer has evolved from just an interesting pharmacokinetic concept into a viable management option for women with advanced disease. Several authors, and among them some of the world's leading experts on this field present the current knowledge and their experience on peritoneal carcinomatosis from ovarian cancer.
Key Features
New
Mint Condition
Dispatch same day for order received before 12 noon
Guaranteed packaging
No quibbles returns
Product Specifications
- Format
- hardcover
- ASIN
- 1594543984
- Domain
- Amazon UK
- Release Date
- 08 April 2005
- Listed Since
- 05 February 2007
Barcode
No barcode data available
Similar Products You Might Like
94% match
Frontiers in Ovarian Cancer Science (Comprehensive Gynecology and Obstetrics)
Springer
£135.35
08 Mar 2026
94% match
Intraperitoneal Therapy for Ovarian Cancer
Springer
£106.59
15 Jan 2026
94% match
Peritoneal Carcinomatosis: Drugs and Diseases: 81 (Cancer Treatment and Research, 81)
Springer
£149.20
10 Mar 2026
94% match
Frontiers in Ovarian Cancer Science (Comprehensive Gynecology and Obstetrics)
Springer
£92.56
06 Mar 2026
94% match
Ovarian Cancer: Second Edition: 149 (Cancer Treatment and Research, 149)
Springer
£80.09
09 Mar 2026
94% match
Peritoneal Carcinomatosis: Principles of Management: 82 (Cancer Treatment and Research, 82)
Springer
£242.71
23 Jan 2026
94% match
Peritoneal Carcinomatosis: Principles of Management: 82 (Cancer Treatment and Research, 82)
Springer
£201.01
23 Jan 2026
93% match
Endometrial Cancer: Clinical and Translational Update Book
£135.73
18 Apr 2026
93% match
Peritoneal Tumors and Metastases: Surgical, intraperitoneal and systemic therapy
Springer
£113.97
09 Mar 2026
93% match
Intraperitoneal Cancer Therapy (Current Clinical Oncology)
Humana
£79.93
06 Mar 2026
93% match
Regional Chemotherapy: Clinical Research and Practice (Current Clinical Oncology)
Humana
£85.07
13 Apr 2026
93% match
Pathology of Peritoneal Metastases: The Unchartered Fields
Springer
£88.34
05 Feb 2026
93% match
Fere Ex Nihilo - Ovarian Oncogenesis Recapitulates Phylogenesis: A Hormonal Approach To Ovarian Cancer Mirroring The Development Of The Mullerian Tract
World Scientific Publishing Company
£84.99
19 Feb 2026
93% match
Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine ... Leukemia, Multiple Myeloma and Sarcoma: 6
Springer
£165.82
14 Jan 2026
93% match
Uterine Cancer: Diagnosis and Treatment
Springer
£93.19
09 Mar 2026
93% match
Peritoneal Carcinomatosis: A Multidisciplinary Approach: 134 (Cancer Treatment and Research, 134)
Springer
£103.00
12 Dec 2025
93% match
Advances in Diagnosis and Management of Ovarian Cancer
Springer
£119.99
01 Mar 2026
93% match
Intraperitoneal Cancer Therapy (Current Clinical Oncology)
Humana
£38.89
09 Jan 2026
93% match
Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond
Springer
£81.28
25 Jan 2026
93% match
Treatment of Peritoneal Metastasis, An Issue of Surgical Oncology Clinics of North America (Volume 27-3) (The Clinics: Surgery, Volume 27-3)
Elsevier
£68.52
28 Feb 2026
93% match
The Tumor Microenvironment of High Grade Serous Ovarian Cancer
MDPI AG
£64.85
19 Apr 2026
93% match
Ovarian Cancer Biomarkers: Mapping to Improve Outcomes
Springer
£103.30
02 Apr 2026
93% match
Springer Ovarian Cancer: Second Edition - Medical Textbook
Springer
£30.42
07 Mar 2026
93% match
Ovarian Cancers: Advances through International Research Cooperation (GINECO, ENGOT, GCIG)
Springer
£87.83
08 Jan 2026